Table 2.
Sample ID | Phenotypic antibiotic susceptibility |
Genotypic antibiotic resistance | PEN phenotype/genotype discordance | Serogroup | MLST | Clonal complex | |||
---|---|---|---|---|---|---|---|---|---|
CHL | CIP | CRO | PEN | ||||||
NM01 | R (128) | S (0.004) | S (<0.016) | I (0.125) | CHL, PEN | B | 1487 | ||
NM03 | S (1) | S (0.004) | S (<0.016) | I (0.25) | PEN | B | 14488 | ST-41/44 complex | |
NM04 | S (2) | S (0.004) | S (<0.016) | S (0.064) | B | 14489 | |||
NM06 | S (2) | S (0.004) | S (<0.016) | S (0.064) | B | 32 | ST-32 complex | ||
NM07 | S (1) | R (0.125) | S (<0.016) | I (0.25) | PEN, CIP, TET | C | 3256 | ||
NM09 | S (2) | S (0.004) | S (<0.016) | S (0.064) | B | 5604 | |||
NM11 | R 128) | S (0.004) | S (<0.016) | S (0.064) | CHL | B | 14496 | ||
NM12 | R (128) | S (0.004) | S (<0.016) | R (0.5) | CHL, PEN | B | 1576 | ||
NM13 | R (128) | S (0.004) | S (<0.016) | S (0.064) | CHL | B | 1576 | ||
NM14 | S (2) | S (0.004) | S (<0.016) | I (0.25) | PEN | B | 1145 | ST-41/44 complex | |
NM15 | S (1) | S (0.008) | S (<0.016) | I (0.25) | PEN | B | 41 | ST-41/44 complex | |
NM16 | R (32) | S 0.032 | S (0.002) | I (0.125) | CHL | Yes | B | 1576 | |
NM18 | R (32) | R (0.25) | S (0.016) | I (0.125) | CHL, CIP, PEN | B | 1576 | ||
NM19 | S (1) | S (0.008) | S (0.016) | S (0.032) | C | 14503 | ST-4821 complex | ||
NM20 | R (32) | S (0.016) | S (0.016) | S (0.064) | CHL, PEN | Yes | B | 11005 | |
NM21 | S (2) | S (0.016) | S (0.016) | S (0.016) | B | 12811 | |||
NM23 | S (2) | S (0.016) | S (0.016) | I (0.125) | PEN | B | 14507 | ||
NM25 | R (32) | S (0.004) | S (0.002) | I (0.25) | CHL, PEN | B | 1576 |
CHL, chloramphenicol; CIP, ciprofloxacin; CRO, ceftriaxone; PEN, penicillin; TET, tetracycline.
S, susceptible; I, intermediate; R, resistant; MIC, minimum inhibitory concentration.